Since we have recently determined that berberine can reduce pAPPThr668, CTFs and amyloid plaque burden in a mouse model of AD [15], we conclude that the Aβ-reducing effect of RC, CP or HLJDT-M may be mainly due to the presence of berberine in HLJDT-M. The gene discussed is CP; the disease is Alzheimer disease.